| 000 | 01868 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511195851.0 | ||
| 264 | 0 | _c19920115 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0021-9541 | ||
| 024 | 7 |
_a10.1002/jcp.1041490322 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPresta, M | |
| 245 | 0 | 0 |
_aBiologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. _h[electronic resource] |
| 260 |
_bJournal of cellular physiology _cDec 1991 |
||
| 300 |
_a512-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Fibroblast Growth Factor |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 700 | 1 | _aRusnati, M | |
| 700 | 1 | _aUrbinati, C | |
| 700 | 1 | _aSommer, A | |
| 700 | 1 | _aRagnotti, G | |
| 773 | 0 |
_tJournal of cellular physiology _gvol. 149 _gno. 3 _gp. 512-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcp.1041490322 _zAvailable from publisher's website |
| 999 |
_c1666960 _d1666960 |
||